Delivery Order SPE2DB22D1103-SPE2DB25FTMT8

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567967405 - LIDOCAINE 5% PATCH 30S. The contract has a firm fixed price of $1,644.48 and an ultimate completion date of April 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,555.69, is for the delivery of 4568038041 - LIDOCAINE 5% PATCH 30S. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LIDOCAINE 5% PATCH 30S. The $11,642.21 firm fixed price contract was awarded on May 16, 2025 by the Defense Logistics Agency (DLA), which is the agency responsible for the Medical Supply Chain. The contract has an ultimate completion date of June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565186003 - LIDOCAINE 5% PATCH 30S, with a ceiling value of $5,002.93 and a period of performance through July 19, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,575.68 firm fixed-price contract is for the delivery of 4567473028 - LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,650.26, is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.56, is for the supply of 4565617850 LIDOCAINE 5% PATCH 30S, a prescription medication. The order has an ultimate completion date of August 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $7,535.01 firm fixed-price contract is for the delivery of 4565655175 - LIDOCAINE 5% PATCH 30S, a medical supply product. The contract has an ultimate completion date of September 4, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.27 delivery order contract is for the provision of 4567887709 LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of April 14, 2025. The contract is a Firm Fixed Price type and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,422.67 firm-fixed-price contract is for the delivery of 4564328080 - LIDOCAINE 5% PATCH 30S, with a completion date of April 19, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTMT8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,459.69 firm fixed-price contract is for the delivery of 4568261561 - LIDOCAINE 5% PATCH 30S, with a completion date of May 16, 2025. The contract is not set aside and was awarded on May 15, 2025.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/14/25, 9:56 AM